Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of $1.08 billion. The enterprise value is $1.34 billion.

Market Cap	1.08B
Enterprise Value	1.34B

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026, after market close.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Teladoc Health has 180.43 million shares outstanding. The number of shares has increased by 3.32% in one year.

Current Share Class	180.43M
Shares Outstanding	180.43M
Shares Change (YoY)	+3.32%
Shares Change (QoQ)	+0.51%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	74.15%
Float	178.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.43
Forward PS	0.42
PB Ratio	0.77
P/TBV Ratio	n/a
P/FCF Ratio	3.79
P/OCF Ratio	3.68
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 40.58, with an EV/FCF ratio of 4.70.

EV / Earnings	n/a
EV / Sales	0.53
EV / EBITDA	40.58
EV / EBIT	n/a
EV / FCF	4.70

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.75.

Current Ratio	2.77
Quick Ratio	2.43
Debt / Equity	0.75
Debt / EBITDA	22.38
Debt / FCF	3.64
Interest Coverage	-8.29

Financial Efficiency

Return on equity (ROE) is -13.93% and return on invested capital (ROIC) is -3.71%.

Return on Equity (ROE)	-13.93%
Return on Assets (ROA)	-3.20%
Return on Invested Capital (ROIC)	-3.71%
Return on Capital Employed (ROCE)	-6.66%
Weighted Average Cost of Capital (WACC)	8.73%
Revenue Per Employee	$451,782
Profits Per Employee	-$35,772
Employee Count	5,600
Asset Turnover	0.79
Inventory Turnover	20.21

Taxes

Income Tax	-35.21M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.67% in the last 52 weeks. The beta is 2.08, so Teladoc Health's price volatility has been higher than the market average.

Beta (5Y)	2.08
52-Week Price Change	-16.67%
50-Day Moving Average	5.33
200-Day Moving Average	6.90
Relative Strength Index (RSI)	61.35
Average Volume (20 Days)	4,452,668

Short Selling Information

The latest short interest is 29.71 million, so 16.47% of the outstanding shares have been sold short.

Short Interest	29.71M
Short Previous Month	31.98M
Short % of Shares Out	16.47%
Short % of Float	16.67%
Short Ratio (days to cover)	6.89

Income Statement

In the last 12 months, Teladoc Health had revenue of $2.53 billion and -$200.32 million in losses. Loss per share was -$1.14.

Revenue	2.53B
Gross Profit	1.76B
Operating Income	-163.40M
Pretax Income	-235.53M
Net Income	-200.32M
EBITDA	33.06M
EBIT	-163.40M
Loss Per Share	-$1.14

Full Income Statement

Balance Sheet

The company has $781.08 million in cash and $1.04 billion in debt, giving a net cash position of -$259.08 million or -$1.44 per share.

Cash & Cash Equivalents	781.08M
Total Debt	1.04B
Net Cash	-259.08M
Net Cash Per Share	-$1.44
Equity (Book Value)	1.39B
Book Value Per Share	7.77
Working Capital	714.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $294.36 million and capital expenditures -$8.89 million, giving a free cash flow of $285.46 million.

Operating Cash Flow	294.36M
Capital Expenditures	-8.89M
Depreciation & Amortization	196.46M
Net Borrowing	-550.63M
Free Cash Flow	285.46M
FCF Per Share	$1.58

Full Cash Flow Statement

Margins

Gross margin is 69.50%, with operating and profit margins of -6.46% and -7.92%.

Gross Margin	69.50%
Operating Margin	-6.46%
Pretax Margin	-9.31%
Profit Margin	-7.92%
EBITDA Margin	1.31%
EBIT Margin	-6.46%
FCF Margin	11.28%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.32%
Shareholder Yield	-3.32%
Earnings Yield	-18.50%
FCF Yield	26.37%

Analyst Forecast

The average price target for Teladoc Health is $7.56, which is 26.00% higher than the current price. The consensus rating is "Buy".

Price Target	$7.56
Price Target Difference	26.00%
Analyst Consensus	Buy
Analyst Count	18
Revenue Growth Forecast (5Y)	2.17%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -6.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.46
Piotroski F-Score	4